Drug
Cetaphil Healing
Cetaphil Healing: highest development phase Post-Market, developed by Galderma. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| "Cetaphil Healing Ointment" NCT06015217 | Post-Market | Diaper Rash |
| Cetaphil Healing Ointment NCT05686928 | Post-Market | Surgical Wound |
Latest
No recent events.
Follow Cetaphil Healing on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.